Hiperandrogenismo femenino

Escobar-Morreale, 2018, Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment, Nat Rev Endocrinol., 14, 270, 10.1038/nrendo.2018.24 Kostakis, 2019, Androgens in menopausal women: not only polycystic ovary syndrome, Front Horm Res., 53, 135, 10.1159/000494909 Álvarez-Blasco, 2006, Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women, Arch Intern Med., 166, 2081, 10.1001/archinte.166.19.2081 The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Human Reproduction., 19, 41, 10.1093/humrep/deh098 Steering Committee of the National Institutes of Health Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome, 2012 Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Hum Reprod., 33, 1602, 10.1093/humrep/dey256 Azziz, 2016, Polycystic ovary syndrome, Nat Rev Dis Primers., 2, 57 Carmina, 2017, Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women, Human Reproduction Update., 23, 580, 10.1093/humupd/dmx014 Elhassan, 2018, Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women, J Clin Endocrinol Metab., 103, 1214, 10.1210/jc.2017-02426 Hague, 1988, Familial polycystic ovaries: a genetic disease?, Clin Endocrinol., 29, 593, 10.1111/j.1365-2265.1988.tb03707.x Vink, 2006, Heritability of polycystic ovary syndrome in a Dutch twin-family study, J Clin Endocrinol Metab., 91, 2100, 10.1210/jc.2005-1494 Escobar-Morreale, 2005, The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome, Endocr Rev., 26, 251, 10.1210/er.2004-0004 Insenser, 2019, Androgen excess in women: proteomic and metabolomic approaches, Front Horm Res., 53, 162, 10.1159/000494910 Azziz, 2016, New insights into the genetics of polycystic ovary syndrome, Nat Rev Endocrinol., 12, 74, 10.1038/nrendo.2015.230 Ortiz-Flores, 2019, Polycystic ovary syndrome in adult women, Med Clin., 152, 450, 10.1016/j.medcli.2018.11.019 Ibáñez, 2006, Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children, J Clin Endocrinol Metab., 91, 2153, 10.1210/jc.2005-2778 Borruel, 2013, Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS), J Clin Endocrinol Metab., 98, 1254, 10.1210/jc.2012-3698 Diamanti-Kandarakis, 2012, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications, Endocr Rev., 33, 981, 10.1210/er.2011-1034 Nestler, 1998, Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system, J Clin Endocrinol Metab., 83, 2001 Martin, 2018, Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline, J Clin Endocrinol Metab., 103, 1233, 10.1210/jc.2018-00241 Ferriman, 1961, Clinical assessment of body hair growth in women, J Clin Endocrinol Metab., 21, 1440, 10.1210/jcem-21-11-1440 Escobar-Morreale, 2012, Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society, Hum Reprod Update., 18, 146, 10.1093/humupd/dmr042 Vermeulen, 1999, A critical evaluation of simple methods for the estimation of free testosterone in serum, J Clin Endocrinol Metab., 84, 3666, 10.1210/jcem.84.10.6079 Alpanes, 2015, Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome, Fertil Steril., 103, 795, 10.1016/j.fertnstert.2014.12.105 Botelho, 2013, Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum, Clin Chem., 59, 372, 10.1373/clinchem.2012.190934 Centers for Disease Control and Prevention, 2019 Dewailly, 2014, Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society, Hum Reprod Update., 20, 334, 10.1093/humupd/dmt061 Bellver, 2018, Polycystic ovary syndrome throughout a woman's life, J Assist Reprod Genet., 35, 25, 10.1007/s10815-017-1047-7 Luque-Ramírez, 2014, Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity, Curr Hypertens Rep., 16, 014, 10.1007/s11906-014-0500-6 Ledger, 2014 Conway, 2014, The polycystic ovary syndrome: a position statement from the European Society of Endocrinology, Eur J Endocrinol., 171, P1, 10.1530/EJE-14-0253 Ortiz-Flores, 2019, Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?, Metabolism., 93, 86, 10.1016/j.metabol.2019.01.015 Markopoulos, 2015, Hyperandrogenism after menopause, Eur J Endocrinol., 172, R79, 10.1530/EJE-14-0468 Balen, 2016, The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance, Hum Reprod Update., 22, 687, 10.1093/humupd/dmw025 Escobar-Morreale, 2017, Prevalence of ‘obesity-associated gonadal dysfunction’ in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis, Hum Reprod Update., 23, 390, 10.1093/humupd/dmx012 Ortiz-Flores, 2018, Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes, Expert Opin Pharmacother., 19, 1915, 10.1080/14656566.2018.1528231 Escobar-Morreale, 2007, Abdominal adiposity and the polycystic ovary syndrome, Trends Endocrinol Metab., 18, 266, 10.1016/j.tem.2007.07.003